A bibliometric analysis of LASER interventional therapy for spinal cord injury: Current situation, hot spots, and global trends DOI Creative Commons

Lu Liu,

Huaneng Wen,

Bingshui Wang

et al.

Asian Journal of Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell‐Derived Extracellular Vesicles DOI Creative Commons

Yuluo Rong,

Jiaxing Wang, Tao Hu

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(31)

Published: June 19, 2024

Abstract Spinal cord injury (SCI) is a severe neurological condition that frequently leads to significant sensory, motor, and autonomic dysfunction. This study sought delineate the potential mechanistic underpinnings of extracellular vesicles (EVs) derived from ginsenoside Rg1‐pretreated neuronal cells (Rg1‐EVs) in ameliorating SCI. These results demonstrated treatment with Rg1‐EVs substantially improved motor function spinal cord‐injured mice. enhance microglial polarization toward M2 phenotype repressed oxidative stress, thereby altering immune responses decreasing inflammatory cytokine secretion. Moreover, diminish reactive oxygen species accumulation enhanced neural tissue repair by regulating mitochondrial function. Proteomic profiling highlighted enrichment MYCBP2 Rg1‐EVs, functional assays confirmed knockdown counteracted beneficial effects vitro vivo. Mechanistically, implicated ubiquitination degradation S100A9, promoting M2‐phenotype reducing stress. Overall, these findings substantiated pivotal role protection recovery following SCI through MYCBP2‐mediated S100A9. research offers novel insights into therapeutic strategies against supports clinical Rg1‐EVs.

Language: Английский

Citations

5

Platelet-rich plasma-derived exosomes promote blood-spinal cord barrier repair and attenuate neuroinflammation after spinal cord injury DOI Creative Commons
Xinyu Nie, Yanting Liu,

Tianyang Yuan

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: July 31, 2024

Spinal cord injury (SCI) compromises the blood-spinal barrier (BSCB) and induces neuroinflammation, potentially exacerbating neuronal damage. This underscores importance of maintaining BSCB integrity mitigating neuroinflammation in SCI treatment. Our study explores an innovative approach to treating by utilizing platelet-rich plasma-derived exosomes (PRP-Exos) stabilize function alleviate neuroinflammation. We successfully isolated from plasma conducted both vivo vitro experiments assess therapeutic effects PRP-Exos explore their potential mechanisms stabilizing BSCB, reducing promoting neural functional recovery.In results demonstrate that significantly reduce permeability bEnd.3 cells under hypoxic-hypoglycemic conditions, thereby restoring tight junctions. Additionally, our elucidates critical role NF-κB signaling pathway amelioration PRP-Exos. In model, local injection hydrogel-encapsulated reduced Evans blue dye leakage, enhanced expression junction proteins, alleviated inflammatory environment damaged area, improved recovery. conclusion, presents a promising effective treatment option for SCI.

Language: Английский

Citations

5

Pre-treated Mesenchymal Stem Cell-Derived Exosomes: A New Perspective for Accelerating Spinal Cord Injury Repair DOI Creative Commons

Zhiqiang Liao,

Jinwei Zeng,

Aiqing Lin

et al.

European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: 992, P. 177349 - 177349

Published: Feb. 5, 2025

Spinal cord injury (SCI) is a devastating event for the central nervous system (CNS), often resulting in loss of sensory and motor functions. It profoundly affects both physiological psychological well-being patients, reducing their quality life while also imposing significant economic pressure on families healthcare system. Due to complex pathophysiology SCI, effective treatments promoting recovery remain scarce. Mesenchymal stem cell-derived exosomes (MSC-Exos) offer advantages such as low immunogenicity, good biocompatibility, ability cross blood-spinal barrier (BSCB). In preclinical studies, they have progressively shown efficacy SCI repair functional recovery. However, yield insufficient targeting MSC-Exos limit therapeutic efficacy. Currently, genetic engineering other preprocessing techniques are being employed optimize properties exosomes, thereby enhancing potential. Therefore, this paper provides an overview biogenesis exosomes. summarizes current approaches optimizing exosome performance. Additionally, it details mechanisms through which optimized provide neuroprotection explores potential combined involving hydrogels.

Language: Английский

Citations

0

Activation of the Nrf2 Signaling Pathway by Tetrahydroberberine Suppresses Ferroptosis and Enhances Functional Recovery Following Spinal Cord Injury DOI
Xiang Li, Heng Yu, Rongjie Liu

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 26, 2025

Language: Английский

Citations

0

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood–Brain Barrier Integrity DOI
Victória Linden de Rezende, Maiara de Aguiar da Costa, Carla Damasio Martins

et al.

Neurochemical Research, Journal Year: 2025, Volume and Issue: 50(2)

Published: March 4, 2025

Language: Английский

Citations

0

Research Progress of Flavonoids in Spinal Cord Injury: Therapeutic Mechanisms and Drug Delivery Strategies DOI
Shizhe Li, Shutao Gao, Yukun Hu

et al.

Phytotherapy Research, Journal Year: 2025, Volume and Issue: unknown

Published: April 2, 2025

Spinal cord injury (SCI) is a serious neurological disease with an extremely high disability rate. Most patients show loss of motor and sensory functions below the level injury. Current treatment protocols are based on early surgical decompression pharmacotherapy. However, efficacy these interventions suboptimal. Due to its complex pathophysiological mechanisms difficulty central nervous system (CNS) regeneration, exploring effective therapeutic remains daunting. Flavonoids secondary metabolites unique plants that have attracted attention in recent years for their potential now commonly used inflammation, tumors, other diseases. For SCI, related studies still exploring; some compounds, such as quercetin, fisetin, hesperetin, shown good anti-inflammatory anti-apoptotic properties, which help restore function injured spinal cord. flavonoids exhibit certain disadvantages, including poor solubility, low bioavailability, inability achieve long-term controlled release. Some proposed drug delivery strategies-including nanoparticles, hydrogels, collagen scaffolds-to enhance efficacy. In this paper, we summarize strategies SCI by searching relevant literature propose future research directions provide new ideas multimodal SCI.

Language: Английский

Citations

0

Schwann Cell-Derived Exosomes Induced Axon Growth after Spinal Cord Injury by Decreasing PTP-σ Activation on CSPGs via the Rho/ROCK Pathway DOI
Shibo Zhu,

Hongpeng Ma,

Mengfan Hou

et al.

Neurochemical Research, Journal Year: 2024, Volume and Issue: 49(8), P. 2120 - 2130

Published: May 31, 2024

Language: Английский

Citations

3

Spinal Cord Injury Management Based on Microglia-Targeting Therapies DOI Open Access
Thomas Gabriel Schreiner,

Oliver Daniel Schreiner,

Romeo Cristian Ciobanu

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(10), P. 2773 - 2773

Published: May 8, 2024

Spinal cord injury is a complicated medical condition both from the clinician's point of view in terms management and patient's perspective unsatisfactory recovery. Depending on severity, this disorder can be devastating despite rapid appropriate use modern imaging techniques convenient surgical spinal decompression stabilization. In context, there mandatory need for novel adjunctive therapeutic approaches to classical treatments improve rehabilitation chances clinical outcomes. This review offers new original therapies targeting microglia, one most relevant immune cells implicated disorders. The first part manuscript reviews anatomical pathophysiological importance blood-spinal barrier components, including role microglia post-acute neuroinflammation. Subsequently, authors present emerging based modulation, such as cytokines modulators, stem cell, microRNA, nanoparticle-based that could positively impact management. Finally, future perspectives challenges are also highlighted ongoing trials related medications microglia.

Language: Английский

Citations

2

Current multi-scale biomaterials for tissue regeneration following spinal cord injury DOI

Y Zhang,

Zhonghuan Wu,

Junfeng Wu

et al.

Neurochemistry International, Journal Year: 2024, Volume and Issue: 178, P. 105801 - 105801

Published: July 5, 2024

Language: Английский

Citations

2

The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases DOI Creative Commons
Mousumi Ghosh, Damien D. Pearse

Cells, Journal Year: 2024, Volume and Issue: 13(22), P. 1834 - 1834

Published: Nov. 6, 2024

Microglia, the resident immune cells of central nervous system (CNS), play a crucial role in maintaining neural homeostasis but can also contribute to disease and injury when this state is disrupted or conversely pivotal neurorepair. One way that microglia exert their effects through secretion small vesicles, microglia-derived exosomes (MGEVs). Exosomes facilitate intercellular communication transported cargoes proteins, lipids, RNA, other bioactive molecules alter behavior internalize them. Under normal physiological conditions, MGEVs are essential homeostasis, whereas dysregulation production and/or alterations have been implicated pathogenesis numerous neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), multiple sclerosis (MS), spinal cord (SCI), traumatic brain (TBI). In contrast, may offer therapeutic potential by reversing inflammation being amenable engineering for delivery beneficial biologics drugs. The determined phenotypic parent microglia. from anti-inflammatory pro-regenerative support neurorepair cell survival delivering neurotrophic factors, mediators, molecular chaperones. Further, deliver components like mitochondrial DNA (mtDNA) proteins damaged neurons enhance cellular metabolism resilience. derived pro-inflammatory detrimental on health. Their cargo often contains cytokines, involved oxidative stress, neurotoxic which exacerbate neuroinflammation, neuronal damage, impair synaptic function, hindering processes. neurodegeneration injury-whether harmful-largely depends how they modulate pro- factors cargo, cytokines microRNAs. addition, propagation pathological such as amyloid-beta alpha-synuclein, progression disorders AD PD, transfer apoptotic necrotic induce neuron toxicity trigger glial scarring during neurological injury. review, we provided comprehensive up-to-date understanding mechanisms underlying multifaceted disease. particular, specific exosome various either recovery, will be discussed. has highlighted methodologies employed cell-selective targeting. Understanding influence balance between signaling CNS developing new strategies diseases neurotrauma.

Language: Английский

Citations

2